We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Labeling Flub Prompts 28,000-Bottle Recall of Abbvie’s Thyroid Drug
Labeling Flub Prompts 28,000-Bottle Recall of Abbvie’s Thyroid Drug
February 4, 2013
Abbvie, the new biopharma spinoff from Abbott Laboratories, is recalling more than 28,000 bottles of its thyroid drug Synthroid due to a labeling error that could result in patients taking the wrong dose.